0000899243-22-015908.txt : 20220428 0000899243-22-015908.hdr.sgml : 20220428 20220428205949 ACCESSION NUMBER: 0000899243-22-015908 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220413 FILED AS OF DATE: 20220428 DATE AS OF CHANGE: 20220428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brigido Stephen CENTRAL INDEX KEY: 0001869791 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38914 FILM NUMBER: 22869535 MAIL ADDRESS: STREET 1: C/O CELULARITY INC. STREET 2: 170 PARK AVENUE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celularity Inc CENTRAL INDEX KEY: 0001752828 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831702591 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 170 PARK AVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: 609-235-1010 MAIL ADDRESS: STREET 1: 170 PARK AVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 FORMER COMPANY: FORMER CONFORMED NAME: GX Acquisition Corp. DATE OF NAME CHANGE: 20180912 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-13 0 0001752828 Celularity Inc CELU 0001869791 Brigido Stephen C/O CELULARITY INC. 170 PARK AVENUE FLORHAM PARK NJ 07932 0 1 0 0 Pres, Functional Regeneration Class A Common Stock 2022-04-13 4 A 0 32809 A 32809 D Stock Option (Right to Buy) 10.16 2022-04-13 4 A 0 96201 0.00 A 2032-04-13 Class A Common Stock 96201 96201 D These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date. This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date. /s/ Keary Dunn, Attorney-in-Fact 2022-04-28